Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Rapid Response: Re: Did the FDA break its own rules in approving the antibiotic Recarbrio? Dear Editor We thank Doshi for investigating FDA failings around the antibiotic Recarbrio (1) and Ross for his commentary about FDA’s industry funding, and corruption of scientific processes. (2) These revelations add to evidence of dangerous mismanagement, strengthening calls for fundamental reform of science and funding at FDA, to restore public trust in drug regulation.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
